TommyBoyTrader

[glenn1919]

OPTT....CSLR......PRPL.........................https://stockcharts.com/h-sc/ui?s=OPTT&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=CSLR&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=PRPL&p=D&yr=0&mn=2&dy=12&id=p84071410134

[glenn1919]

COSM......CARM.......ATER........................https://stockcharts.com/h-sc/ui?s=ATER&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=CARM&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=COSM&p=W&b=5&g=0&id=p84354014936

[glenn1919]

ABAT.....CASI.......ECDA......................https://stockcharts.com/h-sc/ui?s=ABAT&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=CASI&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=ECDA&p=W&b=5&g=0&id=p84354014936

[glenn1919]

SEAT.......BIOL......KALA............https://stockcharts.com/h-sc/ui?s=SEAT&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=KALA&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=BIOL&p=W&b=5&g=0&id=p84354014936

[TommyBoyTrader9460]

$GDVM

$GDVM Starting to make some noise here now that it broke above the 200 day MA.. clear resistance at .30 and should see a nice move higher..
See what else looks good in the Post Masters Telegram Roomhttps://t.co/q0TPsMjKZS#Crypto #RFKJRforPresident #KarenReadTrial pic.twitter.com/dSvQsdxvNl

— Chris from Massachusetts AKA TommyboyTrader (@autumnsdad1) June 30, 2024

[1hunglo]

RDGL-VIVOS ( that performs solid cancerous tumor treatment) submitted an application to the FDA to initiate Human Trials at the Mayo Clinic — within 30 days a decision will be made.

[TommyBoyTrader9460]

$CMND

$CMND Chart setting up nicely for a test of the 200 day MA… like my chances here..#StocksToWatch RFK Jr pic.twitter.com/Emejg7Io9Q

— Chris from Massachusetts AKA TommyboyTrader (@autumnsdad1) June 30, 2024

[Golden Cross]

$EWRC Loading with News on the Way Next Week! Press release next week will encompass current and future projects.
https://x.com/eworld_company
21 Moves Gaming Studios
https://21movesgamingstudios.com

[glenn1919]

IMUX......BIOL......RDZN......POET.....................https://stockcharts.com/h-sc/ui?s=POET&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=RDZN&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=BIOL&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=IMUX&p=D&yr=0&mn=3&dy=0&id=p11960084343

[TommyBoyTrader9460]

That I am..my friend…

[Zardiw]

Was born in a small town close to Munich ......Refer to myself as Bavarian.....NOT german......cause the germans have gotten so stoopid......and they follow the usa around like a piddling puppy dog...........it's heartbreaking.............

Z

[BIOCHEMUP]

You from Europe Zardiw?? Didn’t know that, what country? I’m from Belgium by the way…

[BEIJING BILL]

Been a while my European friend

[Zardiw]

Hey Bill!.........Long time..........

Z

[Solarman]

$MMMW prepares for a marketable stationary solar device to lower electric prices.

[BEIJING BILL]

Howdy my Yankee friend scouit

[BEIJING BILL]

Good day zardiw

[BEIJING BILL]

Ho lee chow he back Chee Chee chee

[Roofus]

RDGL starting to make a move today ….

Far more gains to come.

[TommyBoyTrader9460]

$FFIE

$FFIE On watch here as it’s starting to ramp up into the open with plenty of room to run.. pic.twitter.com/2ub057MTtw

— Chris from Massachusetts AKA TommyboyTrader (@autumnsdad1) June 27, 2024

[glenn1919]

GOVX.......SING.......FFIE.......MULN......https://stockcharts.com/h-sc/ui?s=GOVX&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=SING&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=FFIE&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134

[CK-verse]

$HHSE-NEWS:..HHSE-Approved for OCT..4 Wide-USA-Theatrical-Release..of..WILDFIRE

Tuesday, June 25, 2024

(click on link to view photos)

https://hannoverhousemovies.blogspot.com/2024/06/hhse-approved-for-oct-4-wide-usa.html

At long last - HHSE has been granted approval to commence theatrical marketing, booking and releasing activities for WILDFIRE - which will now launch to theatres on October 4, 2024. Approx. 6-weeks later, our major studio distributor partner will debut the film onto Premium Streaming Services (note: the announcement of our streaming partner is still subject to their timing hold-backs).

We are super-excited to start shipping POSTERS out to theatres... as well as our the debut of our NEW AND INCREDIBLE Wildfire 90-second Trailer. There will also be 15-second and 30-second TV Ad spots, along with Social media campaigns, national TV appearances and the entire gamut of big-PR-noise that accompanies successful family film releases.

How do you go from tiny-revenues to MILLIONS in a month? Release the right product, and that's how major independent studios are built.


Standing room only at the LoneStar Premiere - packed house (excepting only for the front three rows that were roped off by the festival due to being "bad seats") - over 550 persons in the Theatre!

[glenn1919]

WENA................https://stockcharts.com/h-sc/ui?s=WENA&p=D&yr=0&mn=2&dy=12&id=p84071410134

[DawgTrading]

$GGSM No Debts No Liabailities... Profitable

[deri21]

$AURI AURI Adds New Marketing Territories and New CBD, Delta 9, Lion's Mane Products to Knockout Line
https://www.newmediawire.com/news/auri-adds-new-marketing-territories-and-new-cbd-delta-9-lion-s-mane-products-to-knockout-line-7075711

[glenn1919]

BTBT.......BRSH........https://stockcharts.com/h-sc/ui?s=BTBT&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=BRSH&p=W&b=5&g=0&id=p84354014936

[glenn1919]

NCPL......SNTI...........................https://stockcharts.com/h-sc/ui?s=NCPL&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=SNTI&p=D&yr=0&mn=2&dy=12&id=p84071410134

[TommyBoyTrader9460]

$NCPL

$NCPL Looking for a close above the 50 day MA to potentially trigger some buying movement..could test the 200 day MA near term if it does.. pic.twitter.com/j9I3uOWP0h

— Chris from Massachusetts AKA TommyboyTrader (@autumnsdad1) June 25, 2024

[DawgTrading]

$GGSM bids lining up... 3 owned charter boats... 2 cargo boats... AP added to officers.

🚨 $GGSM ┆ Pink Current

🔑 AS:2.20B ┆ OS:1.93B ┆ R:519.41M ┆ UR:1.41B ┆ DTC:1.09B

👤 Company Officer(s)
🟢 Added
- Accounts Payable, Other

— OTCM Tracker (@OTCMTracker) June 24, 2024

[glenn1919]

EVGO......FREY......EOSE................................https://stockcharts.com/h-sc/ui?s=EOSE&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=FREY&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=EVGO&p=W&b=5&g=0&id=p84354014936

[glenn1919]

GOVX.........................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p84354014936

[TommyBoyTrader9460]

$MLGO

$MLGO Got to love the Premarket move here… up 40 percent and trading strong.. pic.twitter.com/ZokFqhtaZj

— Chris from Massachusetts AKA TommyboyTrader (@autumnsdad1) June 24, 2024

[CK-verse]

$HHSE NEWS: MINUTES OF THE BOARD OF DIRECTORS MEETING – June 11, 2024

https://www.otcmarkets.com/otcapi/company/financial-report/405767/content

HANNOVER HOUSE, INC.



1722 N. College Ave. C303, Fayetteville, AR 72703

MINUTES OF THE BOARD OF DIRECTORS MEETING – June 11, 2024



A special meeting of the Board of Directors of Hannover House, Inc. was held on

Tuesday, June 11, 2024 telephonically at 1:30-pm CST. The purpose of this meeting was

to approve certain distribution and financing commitments on behalf of new, feature

film productions being developed by Company and others, as were initiated at the

Cannes, 2024 Film Festival and Marche du Filme. The following items describe the

issues addressed, and where indicated, the actions taken by the Board.


1). TWO MAJOR PRODUCTIONS WITH FORMA FILMZ / HUNGARIAN PARTNERS –

Regarding the film incentives, equity funding and studio co-production opportunities in

Hungary, the Board reviewed the terms of the ventures covering two major feature

productions, each with top commercial stars. Subject to Company’s final approval of the

casting, key personnel, production plans and budgets, the Board approved the issuance

of “soft” distribution guarantees from the Company (e.g., non-recourse commitments”

covering distribution of the films in North America, and / or the sublicensing of said

films to a major studio partner.)



2). ONE MAJOR PRODUCTION WITH TEMPUS PRODUCTIONS – Regarding the epic

action-adventure feature, “TEMPUS PORTA” – featuring three major stars – the Board

reviewed the terms of the production financing arrangements and the benefits to

Hannover House. ventures covering this Malta-based feature production. Subject to

Company’s final approval of the principal casting, key personnel, production plan and

budget, the Board approved the issuance of a “soft” distribution guarantee from the

Company (e.g., a non-recourse commitment” covering distribution of the film in North

America, and / or the sublicensing of said films to a major studio partner).



3). “INDIGENOUS” AND “FADE-‘EM’UP” PRODUCTIONS – Regarding these two USA

based, lower budgeted feature productions, the Board reviewed the production plans

and required financing shortfalls required. The Board agreed to include both

productions into the “use of proceeds” submission for a newly structured, five-million

dollar (USD $5,000,000) off-balance-sheet production equity funding arrangement with

a New York-based private equity fund. As the detailed terms of this new funding venture

are still under negotiation, the Board authorized communications with the production

entities of these two films, with the expression of the Company’s “interest” and “effort” - subject to the closing of the production equity funding venture.

There being no further issues addressed at this meeting, the Board adjourned at 2:25

pm.



SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has

duly caused this report on the Minutes of the Board of Directors Meeting of Hannover

House, Inc. to be signed on its behalf by the undersigned hereunto duly authorized.



HANNOVER HOUSE, INC.

(Registrant)

Date: June 12, 2024

/s/ Eric F. Parkinson

By: ERIC F. PARKINSON

Chairman, C.E.O., President & Secretary

[CK-verse]

$HHSE-NEWS:..General Update and Follow-up on CANNES and Major Activities for HHSE

Sunday, June 2, 2024


https://hannoverhousemovies.blogspot.com/2024/06/general-update-and-follow-up-on-cannes.html

Greetings HHSE Friends - As requested, here are some additional updates on CANNES activities and other general activities for Hannover House, Inc. / MYFLIX and our affiliates.


1). INTERNATIONAL SALES - Direct licenses were made for FRANCE, ITALY and SPAIN on selected HHSE titles, most notably, "UNHOLY SONG: THE EXORCISM OF EVIL." A separate deal was consummated for all sales, licensing and distribution rights to WILDFIRE outside of North America (however, the licensor retains the right to control the timing of the announcement).


2). MULTI-MILLION DOLLAR PRODUCTION FINANCING VENTURES - Although we are still under N.D.A. restrictions on two of the titles, we can announce that major financing was structured for THREE (3) separate major features. Two of these are slated for production in Hungary and Germany (budgets are $6-mm and $12-mm), and one of these is slated for production in Malta and France (TEMPUS PORTA at $20-mm). For the Hungarian-German co-productions, one of the films features a 2023 Academy Award nominated actress, and the other film features one of the highest ranked stars in the world (both in terms of IMDB Star Ranking as well as worldwide box office grosses). The TEMPUS PORTA film includes a venture with the same production company that recently completed GLADIATOR 2 and is now handling the production of JURASSIC WORLD 4. Again, N.D.A. restrictions are required due to the partners and stars involved. Any one of these movies are major "game changers" for HHSE in terms of production fees, distribution fees, profit participation and general stature / credibility for the company. To have three such projects in the same year is beyond significant for the future of HHSE.


3). MYFLIX PARTNER STUDIOS - lots of meetings at Cannes and support and enthusiasm continues high for MyFlix. However, all of the major suppliers agree with the strategy of launching MyFlix with the multi-faceted marketing strategy originally planned for the venture. There was no support, only concern, that buckling to pressure from shareholders to proceed with the venture without proper marketing and ad support would likely result is a failed launch. Timing wise, HHSE has several likely financing sources for MyFlix, all triggered by the current OTC: QB Uplist project.


4). WILDFIRE RELEASE & GENERAL UPDATES - Prior to the major studio streaming launch of this title, HHSE will be given a 60-day window for the exploitation of North American theatrical rights. As of this date, the V.O.D. premiere window date has not been finalized (although, we're being told that it will LIKELY be between Thanksgiving and Christmas this year - prime time for family programming). Accordingly, the most likely theatrical launch date will be MID-SEPTEMBER.

Meanwhile, we have not come to terms with Warner-Chappell Music on the use of our new "WILDFIRE" song master, except for the use of this version withing the movie itself. We will need a separate license for using this recording within a TRAILER, or as a component of a free-standing MUSIC VIDEO. Accordingly, we have pulled down both the trailer version (from last year) and the Anne Heche music video tribute, as these utilized the new master, but did not have the "publishing rights" for these additional uses. We were already making a new trailer for the film which does NOT use our new recording as featured in the movie. It is possible we may go back and license the rights to use our own version of the song for use within a film trailer... but it's also possible that our key distribution partners will agree that the new trailer works very well with the other music already owned outright. So, to be clear: the rights to the "WILDFIRE" song were previously licensed "for use in the movie" but not for other uses. I know it sounds crazy that we cannot use a song master that we own outright, but that's how "music publishing rights" work: the master of a recording and the "copyright elements of the song" are considered two separate assets, each subject to separate licenses. Definitely not a big deal, but we wanted to clarify.


5). OTCQB UPLIST - Yes, still awaiting final audit opinion, but are otherwise ready to submit. There will be no advanced warning at this point. We will publish the OTC:QB documents as soon as the final audit opinion is provided. Could be any day, any moment. As mentioned before, conforming all of our assets, balance sheet items, payables, receivables and contracts is hardest "the first time" - and then these are established assumption items for all subsequent financial reports.

[Roofus]

Yep, and don’t forget $RDGL ….

Cancer treatment stock that is working in a partnership with Mayo Clinic.

Up for FDA approval in the next few days.
Expected to be approved.

Should be a 10 bagger at least for RDGL.

[Zardiw]

#DDAmanda Gold Pick - $BMXI - Video

4th of July Special - #DDAmanda :

https://ddamanda.com/SignUpFourth.php

Z

[Juntao]

BLEG
https://www.otcmarkets.com/stock/BLEG/security

[TommyBoyTrader9460]

$AGFY

$AGFY Strong move Premarket on this one as it broke over the 50 day MA with authority..all eyes on testing the 200 day MA at $1.08 near term.. pic.twitter.com/MxdrCMkBZZ

— Chris from Massachusetts AKA TommyboyTrader (@autumnsdad1) June 24, 2024

[Golden Cross]

$BMXI 3.3M CEO share buy

[Alexulf]

Strong Buy - see investing.com

https://www.investing.com/equities/carpathian-gold-inc.

[TommyBoyTrader9460]

$GRDI

$GRDI Strong move to end the week here..with plenty of room to run.. pic.twitter.com/a5J7ZmJwoJ

— Chris from Massachusetts AKA TommyboyTrader (@autumnsdad1) June 23, 2024

[deri21]

$VTAK Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US based innovative medical device company announced that it has received its first purchase order from Qatar.
https://www.accesswire.com/879363/catheter-precision-inc-announces-receipt-of-first-purchase-order-for-vivo-from-distributor-in-middle-east

[DawgTrading]

$BDCC 3D Construction

$BDCC price starting to come back large spreads... big business in Dubai.https://t.co/HqT8MgSxDP

AL-GHAITH GROUP Consulting with Blackwell 3D construction. pic.twitter.com/ZUlN062I7E

— DawgTrading (@DawgTrading) June 18, 2024

[ProfitScout]

$CYCA News: CyttaAIR Partners with FIZUAS to Dominate the American Drone Reseller and Advanced Streaming Technology Market

Massive Florida Demand for CyttaCOMMS and Drones Drives Partnership

LAS VEGAS, NV / ACCESSWIRE / June 13, 2024 / Cytta Corp (OTCQB:CYCA), a leading provider of innovative technology solutions for public safety and cybersecurity industries, is excited to announce that CyttaAIR, in an expansion of its longstanding reseller partnership with FIZUAS Unmanned Aircraft Systems, a premier national drone reseller, is now entering the drone reseller market. This strategic joint venture aims to meet the growing demand for American-made drones, particularly from law enforcement agencies transitioning away from foreign drones.

A Strategic Move in Response to Growing Demand

This expanded partnership with FIZUAS comes at a critical time when numerous law enforcement agencies in Florida are seeking guidance on which drone brands and models to purchase. This transition to American-made drones is driven by legislative changes and a heightened focus on data security. Through this joint venture, CyttaAIR will provide these agencies with top-tier, compliant drone options, enhancing their operational capabilities and ensuring adherence to new regulations.

Quote from Mike Elliott, VP of Business Development

"We are thrilled to be partnering with a premiere national drone reseller like FIZUAS," said Mike Elliott, VP of Business Development at Cytta Corp. "The number of law enforcement agencies in Florida asking about which drone brands and models to purchase has skyrocketed. This joint venture allows CyttaAIR to expand into this rapidly growing market, providing our clients with the best in American-made drone technology and our leading CyttaCOMMS secure video streaming solution."

Expanding CyttaAIR's Reach

This collaboration is poised to position CyttaAIR as a dominant player in the drone reseller market. By leveraging FIZUAS's extensive reseller network and expertise, CyttaAIR/FIZUAS will jointly offer a comprehensive range of drones equipped with the secure and collaborative capabilities of CyttaCOMMS. This move underscores Cytta Corp.'s commitment to providing cutting-edge technology solutions that meet the evolving needs of law enforcement and other critical sectors.

About Cytta Corp:

Cytta Corp. is a leading technology solutions provider dedicated to delivering innovative products and services across various industries and revolutionizes the integration, streaming, transfer, and storage of video and audio data. With a focus on safety, security, and efficiency, Cytta Corp strives to develop cutting-edge solutions that address real-world challenges in large markets.

The Company's proprietary CyttaCOMMS incident management system offers real-time integration of video and audio streams, enabling improved collaboration and providing ongoing, relevant, actionable intelligence. Their innovative new product, CyttaCARES , is a game-changer in ensuring the safety and well-being of children in educational institutions and beyond. CyttaAIR, a groundbreaking platform designed to innovate and consolidate the best of drone hardware, software, and resources for Federal and State Law Enforcement Agencies. Cytta's CyttaCOMP ISTAR (Intelligence, Surveillance, Target Acquisition and Reconnaissance) technology delivers real-time compression of video streams with ultra-low latency.

About FIZUAS Unmanned Aircraft Systems

FIZUAS is a leading national drone reseller known for providing high-quality, reliable drone solutions to various industries. Their extensive network and extensive first responder and industry expertise make them a trusted partner for organizations looking to integrate drone technology into their operations.

Contact Information
Investor/Shareholder Contact:
Gary Zwetchkenbaum
PlumTree Consulting, LLC.
[e-mail]
Direct: (516)-455-7662

Cytta Corp.
Toll free #: 1 877 CYTTAUS (298 8287)
Call Local: 1 740 CYTTAUS (298 8287)
http://www.cytta.com
[e-mail]

Gary Campbell, CEO
Direct [phone] (or message)
[e-mail]

Mike Elliott, VP of Business Development
[e-mail]
[phone]

SOURCE: Cytta Corp.

[Zardiw]

$CATV going OTCQB!

$CATV Seeking Quotes from PCAOB Auditors. Goal: OTCQB:

Financial Audit Initiatives: In our pursuit of excellence, we are actively seeking quotes from PCAOB accounting firms to conduct a comprehensive financial audit. This step is integral to ensuring transparency, accountability, and the reliability of our financial information. As we embark on this process, we remain dedicated to upholding the highest standards in financial reporting.

https://www.otcmarkets.com/stock/catv/news/Letter-to-Shareholders?id=426302

Z

[ProfitScout]

$CATV: Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector

MIAMI, May 15, 2024 /PRNewswire/ -- 4Cable TV International, Inc. soon to be known as Category V Biotech, Inc. (OTC: CATV) announced today the execution of a Letter of Intent (LOI) to acquire Genetic Networks, LLC (https://geneticnetworks.com/), a leader in applied molecular biology and drug development. Effective May 15, 2024, the LOI signifies Category V Biotech's acquisition of 100% equity interests in Genetic Networks, marking the company's entry into the biotechnology sector of the Cannabis industry and solidifying its position as a fully integrated global leader in this space.

Genetic Networks brings a proprietary platform known as GeneScape™, which facilitates the rapid and unbiased discovery of optimal drug compounds through whole-genome analysis. By integrating functional assays of drug activity and human gene variants, GeneScape™ can identify the most promising targets and compounds for specific diseases, expediting development timelines and reducing costs. This acquisition enables Category V Biotech to expand into the biotech aspect of the Cannabis industry, leveraging Genetic Networks' expertise in accelerating compound discovery and development for pre-clinical and clinical testing.

"We are excited to welcome Genetic Networks into the Category V Biotech family," stated Michael Feldenkrais, CEO of Category V Biotech. "Their state-of-the-art platform and extensive knowledge will be instrumental as we strive to unlock the full potential of Cannabis-based therapeutics. Together, we anticipate bringing novel treatments to patients faster than ever before as regulated FDA products under the new regulatory environment of the United States."

Under the agreement's terms, Category V Biotech will acquire 100% of Genetic Networks. The transaction is expected to conclude in the second quarter of 2024, pending customary closing conditions.

Dr. Gennaro D'Urso, co-founder of Genetic Networks, echoed this enthusiasm, stating, "Category V Biotech shares our dedication to leveraging genetics to revolutionize drug development. By joining forces, we envisage broadening the reach and impact of our platform, ultimately delivering superior medicines to patients in need."

Following the acquisition, Genetic Networks will operate as a wholly owned subsidiary of Category V Biotech, retaining its existing management team and facilities. Category V Biotech plans to leverage Genetic Networks' capabilities across its global Cannabis operations, including cultivation, biotech research, and retail.

This transaction is the culmination of years of discussions, awaiting the right moment for research and development in the United States to create pharmaceutical-grade products using Cannabis. With the recent announcement of the rescheduling of Cannabis from Controlled Substance I to Controlled Substance III, reflecting a change in U.S. policies, the long-awaited strategy can now come to fruition. This shift paves the way for Category V Biotech and Genetic Networks to capitalize on emerging opportunities in the Cannabis industry, driving innovation and advancing therapeutic solutions for patients.

Category V Biotech remains actively engaged in pursuing additional acquisitions in the Cannabis industry as part of its growth strategy, with further transactions expected to be announced in the coming months.

About Genetic Networks, LLC

Genetic Networks, LLC, established in 2015, has been at the forefront of serving three of the top ten bio-pharmaceutical companies with its GeneScape™ technology. GeneScape™ expedites drug asset development through applied molecular biology, offering a multidimensional map of diseases and drugs that integrates genome-wide functional assays of drug activity (H-Tech) and human genes and gene variants (Y-Tech) using proprietary analytics. Genetic Networks' GeneScape™ platform accelerates the discovery and development of optimal candidate compounds for pre-clinical and clinical testing, identifying the optimal intersection between targets and compounds in specific disease spaces through whole-genome genetic perturbation and analysis.

About Category V Biotech, LLC, Inc.

Category V Biotech, LLC, Inc. (OTC: CATV) aims to establish and operate a fully integrated global Cannabis company, encompassing biotech research, cultivation, manufacturing, and retail. Through strategic acquisitions and organic growth, the company strives to emerge as the world's leading provider of pharmaceutical Cannabis- based products and therapies.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements regarding Category V Biotech, LLC's business, which are not historical facts but are based on the company's current beliefs, expectations, and assumptions about its future business, plans, strategies, projections, anticipated events, and trends. Such forward-looking statements are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are beyond the company's control. Actual results and financial conditions may differ materially from those indicated in the forward- looking statements due to various factors. The company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, made from time to time, except as required by law.

SOURCE: 4Cable TV International, Inc a/k/a Category V Biotech, LLC, Inc. (OTC: CATV)

Contact: [e-mail], [phone]

Cision View original content:https://www.prnewswire.com/news-releases/category-v-biotech-inc-announces-letter-of-intent-to-acquire-genetic-networks-expanding-into-biotechnology-sector-302146392.html

SOURCE 4Cable TV International, Inc.

[Impacto]

BSGM look at the chart. Totally oversold
RSI @ 28

[KPIFF-LDDFF]

$LDDFF


U.S Airports Deploying Liberty's HEXWAVE for Employee Screening

Courtesy of Steve_wasi:
https://stocktwits.com/Steve_wasi/message/576463564


https://finance.yahoo.com/news/u-airports-deploying-libertys-hexwave-120000207.html


https://www.reddit.com/r/LibertyDefense/s/0045z9VCxq


"

a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, will be deploying HEXWAVE to US airports in July to meet TSA's National Amendment for Aviation Worker Security Screening.

In April 2023, a mandate was issued requiring U.S. airports to adopt physical screening procedures for employees with access to secure-side areas of the airport. The mandate was further reinforced by a U.S. Court of Appeals decision denying airports the ability to delay the screening process. To implement screening for aviation workers, airports will need technologies that provide a broad range of threat detection that can meet the current screening requirements and those mandated for the future.

Liberty Defense recently announced awards for multiple HEXWAVE's to be deployed at Rochester International Airport and Manchester-Boston Regional Airport. The Company is actively working with several major airports on their screening requirements and anticipates a continuous order flow for the next twelve months as airports finalize their plans. Based on a third-party assessment, the major CAT X, I and II airports in the U.S. would require a total of approximately 500 systems to meet the screening requirements.

Unlike weapon detection technology, HEXWAVE uses millimeter wave, advanced 3D imaging and AI to detect all types of concealed metallic and non-metallic threats and other prohibited items – without the passenger having to divest common items. The system allows for rapid, automated screening using a high-throughput, contactless, walkthrough portal to detect liquid, powder and plastic explosives, 3D printed ghost guns and other threats of concern today that enhanced metal detectors on the market cannot detect.

"Insider threat is a real risk, and we are excited to be working with airports looking to implement next generation technology like the HEXWAVE" said Bill Frain, CEO of Liberty Defense. "The common goal is to provide security while maintaining a seamless process for the employees. The flexibility and portability of the HEXWAVE allows the Airport to quickly deploy and move the HEXWAVE to help meet security screening requirements to areas inside the Airport."

...

The proceeds from the Offering will be used to fund the production of HEXWAVE units (approximately $1 million) and for general corporate and administrative purposes ($500,000).

"

[deri21]

$INBS Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth Initiatives
https://www.globenewswire.com/news-release/2024/06/13/2898264/0/en/Intelligent-Bio-Solutions-Implements-Strategic-Reorganization-Plan-to-Support-Global-Growth-Initiatives.html

[CK-verse]

$HHSE-NEWS: MINUTES OF THE BOARD-OF-DIRECTORS MEETING – June 11, 2024

https://www.otcmarkets.com/otcapi/company/financial-report/405767/content

HANNOVER HOUSE, INC.



1722 N. College Ave. C303, Fayetteville, AR 72703

MINUTES OF THE BOARD OF DIRECTORS MEETING – June 11, 2024



A special meeting of the Board of Directors of Hannover House, Inc. was held on

Tuesday, June 11, 2024 telephonically at 1:30-pm CST. The purpose of this meeting was

to approve certain distribution and financing commitments on behalf of new, feature

film productions being developed by Company and others, as were initiated at the

Cannes, 2024 Film Festival and Marche du Filme. The following items describe the

issues addressed, and where indicated, the actions taken by the Board.


1). TWO MAJOR PRODUCTIONS WITH FORMA FILMZ / HUNGARIAN PARTNERS –

Regarding the film incentives, equity funding and studio co-production opportunities in

Hungary, the Board reviewed the terms of the ventures covering two major feature

productions, each with top commercial stars. Subject to Company’s final approval of the

casting, key personnel, production plans and budgets, the Board approved the issuance

of “soft” distribution guarantees from the Company (e.g., non-recourse commitments”

covering distribution of the films in North America, and / or the sublicensing of said

films to a major studio partner.)



2). ONE MAJOR PRODUCTION WITH TEMPUS PRODUCTIONS – Regarding the epic

action-adventure feature, “TEMPUS PORTA” – featuring three major stars – the Board

reviewed the terms of the production financing arrangements and the benefits to

Hannover House. ventures covering this Malta-based feature production. Subject to

Company’s final approval of the principal casting, key personnel, production plan and

budget, the Board approved the issuance of a “soft” distribution guarantee from the

Company (e.g., a non-recourse commitment” covering distribution of the film in North

America, and / or the sublicensing of said films to a major studio partner).



3). “INDIGENOUS” AND “FADE-‘EM’UP” PRODUCTIONS – Regarding these two USA

based, lower budgeted feature productions, the Board reviewed the production plans

and required financing shortfalls required. The Board agreed to include both

productions into the “use of proceeds” submission for a newly structured, five-million

dollar (USD $5,000,000) off-balance-sheet production equity funding arrangement with

a New York-based private equity fund. As the detailed terms of this new funding venture

are still under negotiation, the Board authorized communications with the production

entities of these two films, with the expression of the Company’s “interest” and “effort” - subject to the closing of the production equity funding venture.

There being no further issues addressed at this meeting, the Board adjourned at 2:25

pm.



SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has

duly caused this report on the Minutes of the Board of Directors Meeting of Hannover

House, Inc. to be signed on its behalf by the undersigned hereunto duly authorized.



HANNOVER HOUSE, INC.

(Registrant)

Date: June 12, 2024

/s/ Eric F. Parkinson

By: ERIC F. PARKINSON

Chairman, C.E.O., President & Secretary